Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group.

BACKGROUND AND PURPOSE Serial ultrasonic B-mode measurements of intimal-medial thickness (IMT) of the carotid artery are commonly used as surrogates for describing atherosclerosis progression. This report describes the longitudinal reliability of IMT measurement during a multicenter clinical trial, quantifies the error attributable to differences among readers, and discusses how studies can be efficiently designed. METHODS Serial B-mode measurements of carotid IMT from the 3-year Asymptomatic Carotid Artery Progression Study (ACAPS; formerly Asymptomatic Carotid Artery Plaque Study) were used to estimate the contributions to longitudinal measurement error of systematic reader effects, nonvisualization, and nonsystematic error and to describe the distribution of "true" progression rates that underlie the observed data. Variance components were estimated from random-effects models fitted to outcome measures formed by averaging IMTs from different sets of carotid artery walls. These were used to contrast the relative efficiency of study designs. RESULTS Of the total variance of measured IMT, 11% was attributable to systematic differences among readers. Nonvisualization contributed less than 7%. Thus, the predominant source of error was unaccounted for (ie, random error or "noise," which in our analyses included any drift, nonlinearity, and sonographer differences). For studies with measurement protocols similar to ACAPS, follow-up times of 2 years or more are desirable for describing the mean progression rates of cohorts, and of 6 years or more for categorizing progression within individuals. In 3-year studies, sample sizes as low as 237 provide 90% statistical power for detecting risk factors that have correlations with IMT progression of .50 or greater. CONCLUSIONS The ACAPS measurement protocol provided highly reliable serial IMT data. Moderate-sized multicenter studies using B-mode outcomes are feasible.

[1]  M. Espeland,et al.  Analysis strategies for serial multivariate ultrasonographic data that are incomplete. , 1992, Statistics in medicine.

[2]  C. Furberg,et al.  Effect of Cholesterol-Lowering Medications on Progression of Mild Atherosclerotic Lesions of the Carotid Arteries and on the Risk of Stroke , 1995 .

[3]  O. Wiklund,et al.  Frontiers in cardiovascular science. Quantitative measurements of atherosclerotic manifestations in humans. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  N. Borhani,et al.  Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study. , 1993, American journal of hypertension.

[5]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[6]  G. W. Snedecor.  Statistical Methods , 1964 .

[7]  T. Craven,et al.  Prognostic Significance of Progression of Coronary Atherosclerosis , 1993, Circulation.

[8]  B M Psaty,et al.  Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1991, Stroke.

[9]  F. A. Bryan,et al.  Measurement variability of carotid atherosclerosis: real-time (B-mode) ultrasonography and angiography. , 1987, Stroke.

[10]  C. Furberg,et al.  Quality control in ultrasound studies on atherosclerosis , 1994, Journal of internal medicine.

[11]  J. Edelstein,et al.  Ultrasonic-pathological comparison of the human arterial wall. Verification of intima-media thickness. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[13]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[14]  G. Berglund,et al.  Noninvasive quantification of atherosclerotic lesions. Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  M. Waki,et al.  Noninvasive quantitative evaluation of early atherosclerosis and the effect of monatepil, a new antihypertensive agent. An interim report. , 1994, American journal of hypertension.

[16]  Short-Term Evaluation of Plaque Area Measurement Reproducibility from Computer-Assisted Sonography , 1995, Angiology.

[17]  J. Salonen,et al.  Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. , 1990, Atherosclerosis.

[18]  L. Chambless,et al.  High‐Resolution B‐Mode Ultrasound Reading Methods in the Atherosclerosis Risk in Communities (ARIC) Cohort , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[19]  R. Jennrich,et al.  Unbalanced repeated-measures models with structured covariance matrices. , 1986, Biometrics.

[20]  R W Barnes,et al.  Reproducibility of Noninvasive Ultrasonic Measurement of Carotid Atherosclerosis: The Asymptomatic Carotid Artery Plaque Study , 1992, Stroke.

[21]  C. Furberg,et al.  Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome. , 1992, Controlled clinical trials.

[22]  M. Bond,et al.  Baseline reproducibility of B-mode ultrasound imaging measurements of carotid intima media thickness: the multicenter isradipine diuretic atherosclerosis study (MIDAS) , 1993 .

[23]  P Pignoli,et al.  Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. , 1986, Circulation.

[24]  C. Furberg,et al.  Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.

[25]  M. Hennerici,et al.  Regression of carotid plaques during low density lipoprotein cholesterol elimination. , 1991, Stroke.

[26]  J. Toole,et al.  Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. , 1990, Circulation.

[27]  T. Craven,et al.  Lessons learned from clinical trials with ultrasound end‐points , 1994, Journal of internal medicine.

[28]  D. Bates,et al.  Newton-Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures Data , 1988 .

[29]  K Rosenfield,et al.  Three-dimensional reconstruction of human carotid arteries from images obtained during noninvasive B-mode ultrasound examination. , 1992, The American journal of cardiology.

[30]  J. Jaffe,et al.  3‐dimensional sonographic analysis based on color flow Doppler and gray scale image data: a preliminary report , 1992, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[31]  J. Toole,et al.  Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  W. Mack,et al.  Beneficial Effects of Colestipol‐Niacin Therapy on the Common Carotid Artery. Two‐ and Four‐Year Reduction of Intima‐Media Thickness Measured by Ultrasound , 1993, Circulation.